{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-100852","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2022-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.544236+00:00","generated_at":"2026-06-23T09:03:04.193252+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kiora Pharmaceuticals names Melissa Tosca EVP of Finance; shareholders approve warrant share issuance","bullets":["Melissa Tosca appointed EVP of Finance effective Sept 13, 2022; will serve as principal accounting and financial officer.","Tosca receives $300K base salary, target bonus up to 25%, and option to purchase 300,000 shares vesting over 3 years.","Stockholders approved issuance of up to 60,191,394 shares upon exercise of Class A and B Warrants from July 2022 offering.","Ratified EisnerAmper as independent auditor for FY2022; adjournment proposal also approved but not needed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-100852","json":"https://secwatch.observer/filing/0001104659-22-100852.json","markdown":"https://secwatch.observer/filing/0001104659-22-100852.md","text":"https://secwatch.observer/filing/0001104659-22-100852.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922100852/0001104659-22-100852-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922100852/tm2226014d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T09:03:04.193252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a9bc1dfa7c","claim":"Melissa Tosca was appointed as Executive Vice President of Finance at KIORA PHARMACEUTICALS INC.","evidence_excerpt":"On September 13, 2022 (the “Effective Date”), Kiora Pharmaceuticals Inc. (the “Company”) appointed Melissa Tosca as Executive Vice President of Finance of the Company, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922100852/0001104659-22-100852-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President of Finance"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}